Boston’s Top 10 VC Deals of Q4: Warp Drive, Rapid7, & More

1/20/12Follow @gthuang

We’ve recently reported on venture capital deal trends from last quarter—for example, Massachusetts regained its No. 2 ranking behind California and ahead of New York in dollars and deals—but let’s take a closer look at some of those deals.

Of the Boston area’s 10 biggest venture investment deals from the fourth quarter of 2011, six were in life sciences and four were in software and tech. The fields of genomics, obesity drugs, nano-drugs, security software, and data management were among those represented.

So here are the top 10 deals (and links to our coverage), as tabulated by Dow Jones VentureSource:

1. Warp Drive Bio, Cambridge, MA, $125 million (story)

2. Agios Pharmaceuticals, Cambridge, MA, $78 million (story)

3. Rapid7, Boston, MA, $50 million (story)

4. Selecta Biosciences, Watertown, MA, $47.25 million (story)

5. BIND Biosciences, Cambridge, MA, $47.25 million (story)

6. Cyber-Ark Software, Newton, MA, $40 million (story)

7. Zink Imaging, Bedford, MA, $35 million (story)

8. Ember Therapeutics, Boston, MA, $34.19 million (story)

9. Actifio, Waltham, MA, $33.5 million (story)

10. Acceleron Pharma, Cambridge, MA, $30.47 million (story)

Gregory T. Huang is Xconomy's Deputy Editor, National IT Editor, and the Editor of Xconomy Boston. You can e-mail him at gthuang@xconomy.com or call him at 617-252-7323. Follow @gthuang

By posting a comment, you agree to our terms and conditions.